Form 483

Central Solutions, Inc. Form 483, 2015-07-10

FDA issued a Form 483 to Central Solutions, Inc. on 2015-07-10 with 21 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health21 observations

Central Solutions, Inc. · Kansas City, United States · Issued July 10, 2015

Overview

  • 21 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

10 Jul 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Jonathan R Campos, Mary K Concannon

10 Jul 2015
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Jonathan R Campos, Mary K Concannon

10 Jul 2015
21 CFR 211.165(e)

Test methods

Cited by Jonathan R Campos, Mary K Concannon

10 Jul 2015
21 CFR 211.180(e)(2)

Items to cover on annual reviews

Cited by Jonathan R Campos, Mary K Concannon

10 Jul 2015
21 CFR 211.25(c)

Inadequate number of personnel

Cited by Jonathan R Campos, Mary K Concannon

Inspected site

CSCentral Solutions, Inc.Kansas City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations3x
21 CFR 211.113(a)Cited across public-safe Form 483 observations3x
21 CFR 211.165(e)Cited across public-safe Form 483 observations3x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations3x
21 CFR 211.25(c)Cited across public-safe Form 483 observations3x
21 CFR 211.68(a)Cited across public-safe Form 483 observations3x
21 CFR 820.80(d)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 21 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere